The technique would retrain cells that typically don't respond to light.
One biotech startup wants to restore vision in blind patients with a gene therapy that gives light sensitivity to neurons that don't normally possess it.
Read more http://feeds.technologyreview.com/click.phdo?i=a4527db9f9245a6e2f5e933043e0a1bf